| 股號 / 名稱 | 現金及約當現金 | 流動資產 | 總資產 |
| ABBV 艾伯維 | 5,629,000,000.0 | 28,539,000,000.0 | 133,898,000,000.0 |
| AZN AstraZeneca PLC | 8,143,000,000.0 | 29,940,000,000.0 | 114,456,000,000.0 |
| BMY 施貴寶 | 15,726,000,000.0 | 35,630,000,000.0 | 96,889,000,000.0 |
| AMGN 美國安進 | 9,445,000,000.0 | 27,885,000,000.0 | 90,141,000,000.0 |
| GILD 吉利德科學 | 7,330,000,000.0 | 17,874,000,000.0 | 58,533,000,000.0 |
| REGN 雷傑納榮製藥 | 2,506,400,000.0 | 17,980,700,000.0 | 40,169,400,000.0 |
| BIIB Biogen Inc | 3,862,800,000.0 | 8,936,600,000.0 | 29,207,500,000.0 |
| BNTX Biontech SE | 11,844,825,582.0 | 18,578,592,906.0 | 25,045,488,138.0 |
| VRTX 福泰製藥 | 4,939,600,000.0 | 10,569,600,000.0 | 24,862,300,000.0 |
| MRNA 莫德納 | 1,132,000,000.0 | 6,598,000,000.0 | 12,135,000,000.0 |
| BIO.B Bio Rad Laboratories Inc | 395,800,000.0 | 2,842,000,000.0 | 9,696,400,000.0 |
| BMRN BioMarin Pharmaceutical Inc | 1,250,108,000.0 | 3,854,543,000.0 | 7,614,868,000.0 |
| GMAB Genmab A/S | 1,761,000,000.0 | 4,471,000,000.0 | 7,021,000,000.0 |
| QGEN Qiagen NV | 1,355,594,000.0 | 2,530,937,000.0 | 6,553,497,000.0 |
| INCY 英賽德 | 2,455,006,000.0 | 4,277,889,000.0 | 6,330,356,000.0 |
| ILMN Illumina Inc | 1,050,000,000.0 | 2,796,000,000.0 | 6,177,000,000.0 |
| EXAS Exact Sciences Corp | 789,037,000.0 | 1,590,726,000.0 | 5,900,009,000.0 |
| ROIV Roivant Sciences Ltd | 1,237,010,000.0 | 4,511,646,000.0 | 5,062,598,000.0 |
| ALNY Alnylam Pharmaceuticals Inc | 1,490,249,000.0 | 3,952,811,000.0 | 4,851,662,000.0 |
| GLPG Galapagos NV | 75,646,619.64 | 3,710,884,605.18 | 4,121,512,032.12 |
| SRPT Sarepta Therapeutics Inc | 613,077,000.0 | 2,722,309,000.0 | 3,493,437,000.0 |
| PCVX Vaxcyte Inc | 281,080,000.0 | 1,767,167,000.0 | 3,171,600,000.0 |
| RGEN Repligen Corp | 748,747,000.0 | 1,096,485,000.0 | 2,923,711,000.0 |
| EXEL Exelixis Inc | 376,300,000.0 | 1,402,257,000.0 | 2,823,547,000.0 |
| TECH Bio-Techne Corp | 144,962,000.0 | 609,507,000.0 | 2,526,148,000.0 |
| INSM Insmed Inc | 334,764,000.0 | 1,931,807,000.0 | 2,360,736,000.0 |
| ALKS Alkermes Plc | 616,449,000.0 | 1,741,664,000.0 | 2,329,512,000.0 |
| CRSP CRISPR Therapeutics AG | 286,497,000.0 | 1,929,092,000.0 | 2,245,308,000.0 |
| HALO Halozyme Therapeutics Inc | 419,665,000.0 | 1,328,749,000.0 | 2,221,232,000.0 |
| RNA Avidity Biosciences Inc | 350,158,000.0 | 1,966,017,000.0 | 2,134,209,000.0 |
| HCM HUTCHMED (China) Ltd | 110,719,000.0 | 1,592,327,000.0 | 1,775,940,000.0 |
| LEGN Legend Biotech Corp | 278,893,000.0 | 1,242,004,000.0 | 1,712,948,000.0 |
| CERT Certara Inc | 172,711,000.0 | 283,303,000.0 | 1,535,856,000.0 |
| LGND Ligand Pharmaceuticals Inc | 139,376,000.0 | 753,920,000.0 | 1,476,772,000.0 |
| EBS Emergent BioSolutions Inc | 245,500,000.0 | 786,900,000.0 | 1,461,000,000.0 |
| CYTK Cytokinetics Inc | 225,467,000.0 | 977,349,000.0 | 1,436,557,000.0 |
| ANIP ANI Pharmaceuticals Inc | 262,610,000.0 | 698,402,000.0 | 1,408,152,000.0 |
| NEO Neogenomics Inc | 164,117,000.0 | 382,465,000.0 | 1,374,780,000.0 |
| ABCL Abcellera Biologics Inc | 83,159,000.0 | 695,140,000.0 | 1,355,992,000.0 |
| ASND Ascendis Pharma A/S | 632,667,589.36 | 1,194,447,425.98 | 1,355,191,505.0 |
| CVAC CureVac NV | 488,314,902.2 | 1,024,665,607.38 | 1,336,260,486.02 |
| ACAD ACADIA Pharmaceuticals Inc | 257,996,000.0 | 1,076,422,000.0 | 1,330,771,000.0 |
| BEAM Beam Therapeutics Inc | 267,960,000.0 | 1,098,547,000.0 | 1,311,081,000.0 |
| GH Guardant Health Inc | 580,013,000.0 | 828,885,000.0 | 1,276,786,000.0 |
| KRYS Krystal Biotech Inc | 392,604,000.0 | 925,650,000.0 | 1,240,094,000.0 |
| HRMY Harmony Biosciences Holdings Inc | 646,999,000.0 | 838,800,000.0 | 1,208,218,000.0 |
| RARE Ultragenyx Pharmaceutical Inc | 202,510,000.0 | 643,206,000.0 | 1,190,445,000.0 |
| DNA Ginkgo Bioworks Holdings Inc | 111,065,000.0 | 506,082,000.0 | 1,189,165,000.0 |
| IDYA IDEAYA Biosciences Inc | 298,927,000.0 | 802,655,000.0 | 1,185,136,000.0 |
| NVAX Novavax Inc | 268,023,000.0 | 974,590,000.0 | 1,179,889,000.0 |
| ZLAB Zai Lab Ltd | 717,155,000.0 | 1,032,948,000.0 | 1,158,940,000.0 |
| IMCR Immunocore Holdings PLC | 498,413,000.0 | 1,022,848,000.0 | 1,102,500,000.0 |
| KYMR Kymera Therapeutics Inc | 112,949,000.0 | 528,298,000.0 | 1,102,044,000.0 |
| APLS Apellis Pharmaceuticals Inc | 479,171,000.0 | 990,676,000.0 | 1,058,723,000.0 |
| DNLI Denali Therapeutics Inc | 90,963,000.0 | 882,598,000.0 | 1,055,621,000.0 |
| TGTX TG Therapeutics Inc | 74,081,000.0 | 599,765,000.0 | 1,025,024,000.0 |
| JANX Janux Therapeutics Inc | 48,389,000.0 | 998,086,000.0 | 1,024,766,000.0 |
| VIR Vir Biotechnology Inc | 170,084,000.0 | 545,684,000.0 | 1,019,453,000.0 |
| AKRO Akero Therapeutics Inc | 176,032,000.0 | 754,535,000.0 | 1,005,577,000.0 |
| NUVL Nuvalent Inc | 115,752,000.0 | 956,945,000.0 | 979,910,000.0 |
| RCUS Arcus Biosciences Inc | 238,000,000.0 | 857,000,000.0 | 974,000,000.0 |
| DVAX Dynavax Technologies Corp | 160,247,000.0 | 814,331,000.0 | 946,506,000.0 |
| NTLA Intellia Therapeutics Inc | 193,389,000.0 | 581,941,000.0 | 925,275,000.0 |
| IOVA Iovance Biotherapeutics Inc | 158,134,000.0 | 429,091,000.0 | 904,948,000.0 |
| MRUS Merus NV | 367,491,000.0 | 691,929,000.0 | 904,196,000.0 |
| QURE Uniqure NV | 597,056,000.0 | 716,193,000.0 | 888,382,000.0 |
| FOLD Amicus Therapeutics Inc | 190,553,000.0 | 594,066,000.0 | 868,811,000.0 |
| MRVI Maravai LifeSciences Holdings Inc | 243,574,000.0 | 325,867,000.0 | 849,191,000.0 |
| ARVN Arvinas Inc | 101,500,000.0 | 826,300,000.0 | 844,300,000.0 |
| MIRM Mirum Pharmaceuticals Inc | 282,021,000.0 | 530,575,000.0 | 785,115,000.0 |
| MESO Mesoblast Ltd | 161,158,000.0 | 204,350,000.0 | 784,683,000.0 |
| BCYC Bicycle Therapeutics PLC | 648,325,000.0 | 738,819,000.0 | 763,954,000.0 |
| CRMD CorMedix Inc | 48,493,080.0 | 259,535,270.0 | 750,861,480.0 |
| KROS Keros Therapeutics Inc | 693,472,000.0 | 719,307,000.0 | 742,783,000.0 |
| VKTX Viking Therapeutics Inc | 100,376,000.0 | 738,703,000.0 | 739,415,000.0 |
| MYGN Myriad Genetics Inc | 145,400,000.0 | 344,800,000.0 | 728,100,000.0 |
| KNSA Kiniksa Pharmaceuticals International PLC | 174,858,000.0 | 475,530,000.0 | 712,333,000.0 |
| PTGX Protagonist Therapeutics Inc | 113,713,000.0 | 586,424,000.0 | 701,688,000.0 |
| AXSM Axsome Therapeutics Inc | 325,272,000.0 | 565,342,000.0 | 669,250,000.0 |
| AUTL Autolus Therapeutics PLC | 86,124,000.0 | 514,577,000.0 | 661,947,000.0 |
| AMRN Amarin Corporation PLC | 122,802,000.0 | 628,334,000.0 | 659,814,000.0 |
| ACLX Arcellx Inc | 79,005,000.0 | 472,081,000.0 | 655,918,000.0 |
| KURA Kura Oncology Inc | 95,287,000.0 | 620,663,000.0 | 649,381,000.0 |
| CLDX Celldex Therapeutics Inc | 36,037,000.0 | 604,339,000.0 | 648,439,000.0 |
| TWST Twist Bioscience Corp | 183,049,000.0 | 332,966,000.0 | 641,861,000.0 |
| IMTX Immatics NV | 393,057,760.76 | 537,526,632.34 | 608,568,124.06 |
| XENE Xenon Pharmaceuticals Inc | 104,514,000.0 | 480,137,000.0 | 607,836,000.0 |
| NUVB Nuvation Bio Inc | 98,897,000.0 | 577,530,000.0 | 601,561,000.0 |
| VNDA Vanda Pharmaceuticals Inc | 70,022,000.0 | 367,496,000.0 | 601,140,000.0 |
| EWTX Edgewise Therapeutics Inc | 46,003,000.0 | 573,900,000.0 | 583,466,000.0 |
| IMVT Immunovant Inc | 521,870,000.0 | 573,546,000.0 | 582,959,000.0 |
| VRDN Viridian Therapeutics Inc | 169,647,000.0 | 571,913,000.0 | 577,138,000.0 |
| ADMA ADMA Biologics Inc | 61,385,000.0 | 402,655,000.0 | 568,687,000.0 |
| GERN Geron Corp | 78,117,000.0 | 522,342,000.0 | 567,382,000.0 |
| CSTL Castle Biosciences Inc | 85,556,000.0 | 357,569,000.0 | 562,786,000.0 |
| PRTC PureTech Health PLC | 260,604,000.0 | 344,388,000.0 | 553,242,000.0 |
| SNDX Syndax Pharmaceuticals Inc | 116,808,000.0 | 529,830,000.0 | 551,792,000.0 |
| TVTX Travere Therapeutics Inc | 110,930,000.0 | 371,110,000.0 | 538,581,000.0 |
| TARS Tarsus Pharmaceuticals Inc | 112,724,000.0 | 501,704,000.0 | 534,561,000.0 |
| RGNX Regenxbio Inc | 58,802,000.0 | 331,967,000.0 | 525,203,000.0 |
載入數據中...
最新要聞
和生物製藥相關的產業概念股
生物製藥概念股相關指標排名
生物製藥每月營收
生物製藥每股盈餘
生物製藥每股淨值
生物製藥損益表
生物製藥總資產
生物製藥負債和股東權益
生物製藥現金流量表
生物製藥利潤比率
生物製藥營業費用率拆解
生物製藥杜邦分析
生物製藥ROE / ROA
生物製藥經營週轉能力
生物製藥營運週轉天數
生物製藥現金股利發放率
生物製藥財務結構比率
生物製藥流速動比率
生物製藥利息保障倍數
生物製藥現金流量分析
生物製藥營業現金流對淨利比
生物製藥盈餘再投資比率
生物製藥月營收成長率
生物製藥營收成長率
生物製藥毛利成長率
生物製藥營業利益成長率
生物製藥稅後淨利成長率
生物製藥每股盈餘成長率
生物製藥本益比評價
生物製藥股價淨值比評價
生物製藥現金股利殖利率
生物製藥平均現金股息殖利率
生物製藥董監持股比例
生物製藥董監持股質押比例